Tata Consultancy Services Helps QIAGEN to Increase Customer Engagement and Provide a Better User Experience with the Rearchitected GeneGlobe – Design & Analysis Hub
MUNICH | MUMBAI: Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT service, consulting and business solutions organization, has transformed QIAGEN’s GeneGlobe, a genomics-based research platform for biology and biomedical researchers, to improve customer experience.
QIAGEN is a leading provider of sample to insight solutions for customers in life sciences and molecular diagnostics. To cater to the expectations of a large proportion of researchers who are digital natives, it was looking to transform its GeneGlobe research platform. The company partnered with TCS given its deep contextual knowledge, strong digital capabilities in cloud and microservices, as well as expertise in designing intuitive, customer-centric platforms.
TCS adopted a cloud-based microservices architecture and revamped the GeneGlobe platform by leveraging industry-best DevOps practices and design thinking approaches. The new platform, GeneGlobe – Design & Analysis Hub, offers an intuitive interface, helping researchers to find the right product in just three steps.
Powerful algorithms link products to biological targets, so researchers can explore and expedite decisions on products within the relevant context. Personalized dashboards and product builders are now easier to use and enable the creation of virtually any custom product for a specific research question. This transformation has helped QIAGEN to boost overall digital revenue.
“We are excited that the new GeneGlobe Design & Analysis Hub is now available and ready to provide customers with next-level experiment planning, execution, and follow-up. With GeneGlobe we are offering researchers one place to navigate knowledge, tools, and analyses for their specific target, saving researchers time and budget,” said Peter Rene Hesse, Head of Digitalization, QIAGEN Life Sciences Business. “The partnership with TCS helps us to drive growth and transformation aligned with our company vision of making improvements in life possible.”
“Our long-term strategic partnership with TCS has allowed us to tap into their deep contextual knowledge of the life sciences industry. This has continuously paid dividends both to the overall success of our business and, more importantly, to the experience we’re able to provide to our customers,” saidDr Thomas Schweins, Senior Vice President and Head, Life Sciences Business, QIAGEN.
“With the new intuitive, customer-centric design and scalable cloud-native architecture, QIAGEN’s platform delivers a superior user experience that will attract a new class of researchers, and accelerate and spur new research that improves lives,” said Vikas Jain, Business Head, Life Sciences, TCS. “Our ability to harness the power of digital technologies to reimagine business models and enhance customer experiences has made us the preferred transformation partner to our life sciences customers in their Business 4.0™ journeys.”
TCS partners with leading life sciences companies to enable their digital transformation journey by leveraging its Business 4.0 framework. TCS offers a full set of digital transformation services and solutions including advisory services, predictive and prescriptive analytics, genomics research, advanced platform solutions, digital content factory, digital marketing, and cognitive business operations.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!
Notify me of follow-up comments by email.
Notify me of new posts by email.
EXIM Board Approves $91.5 Million in U.S. Export Financing for Renewable Energy Rural Electrification Project in Senegal
Why Choose Engineering & which is the Best Engineering College?
HDFC Life offers an additional payment option in partnership with Insurepay.in to support customers
Zoomcar steps up to assist amidst nationwide lockdown due to COVID-19
Bharti Enterprises commits over Rs 100 crore to support India’s battle against COVID-19
2014 The Global Indian New Network (TGINN)